{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:27:08Z","timestamp":1791516428012,"version":"4.3.4"},"reference-count":104,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.ymgme.2022.02.002","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T18:21:27Z","timestamp":1644949287000},"page":"311-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Clinical and biochemical footprints of inherited metabolic disorders. VII. Ocular phenotypes"],"prefix":"10.1016","volume":"135","author":[{"given":"Alejandro","family":"Garanto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos R.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camiel J.F.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara D.M.","family":"van Karnebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0005","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ymgme.2019.03.007","article-title":"Clinical and biochemical footprints of inherited metabolic diseasesI. Movement disorders","volume":"127","author":"Ferreira","year":"2019","journal-title":"Mol. Genet. Metabolism"},{"issue":"2","key":"10.1016\/j.ymgme.2022.02.002_bb0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ymgme.2019.04.002","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases","volume":"127","author":"Ferreira","year":"2019","journal-title":"Molecular Genetics and Metabolism"},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2020.02.007","article-title":"Clinical and biochemical footprints of inherited metabolic diseasesIII. Psychiatric presentations","volume":"130","author":"Horvath","year":"2020","journal-title":"Molecular Genetics and Metabolism"},{"issue":"2","key":"10.1016\/j.ymgme.2022.02.002_bb0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ymgme.2020.12.290","article-title":"Clinical and biochemical footprints of inherited metabolic diseasesIV. Metabolic cardiovascular disease","volume":"132","author":"Ferreira","year":"2021","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1016\/j.ymgme.2022.02.002_bb0025","series-title":"Molecular Genetics and Metabolism","article-title":"Clinical and biochemical footprints of inherited metabolic disease. V. Cerebral palsy phenotypes","author":"Horvath","year":"2021"},{"key":"10.1016\/j.ymgme.2022.02.002_bb0030","article-title":"Clinical and biochemical footprints of inherited metabolic diseases. VI. Metabolic dermatoses","author":"Ferreira","year":"2021","journal-title":"Molecular Genetics and Metabolism"},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/gim.2017.108","article-title":"Knowledge base and mini-expert platform for the diagnosis of inborn errors of metabolism","volume":"20","author":"Lee","year":"2018","journal-title":"Genetics in Medicine"},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0040","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41436-018-0022-8","article-title":"A proposed nosology of inborn errors of metabolism","volume":"21","author":"Ferreira","year":"2019","journal-title":"Genetics in Medicine"},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jimd.12348","article-title":"An international classification of inherited metabolic disorders (ICIMD)","volume":"44","author":"Ferreira","year":"2021","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1016\/j.ymgme.2022.02.002_bb0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2415-2-2","article-title":"The significance of opthalmologic evaluation in the early diagnosis of inborn errors of metabolism: the cretan experience","volume":"2","author":"Tsagaraki","year":"2002","journal-title":"BMC Ophthalmol."},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/jovr.jovr_242_16","article-title":"Ophthalmologic findings in patients with neuro-metabolic disorders","volume":"13","author":"Jafari","year":"2018","journal-title":"J. Ophthalmic Vis. Res."},{"issue":"3","key":"10.1016\/j.ymgme.2022.02.002_bb0060","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ejpn.2011.03.005","article-title":"The eye in metabolic diseases: clues to diagnosis","volume":"15","author":"Poll-The","year":"2011","journal-title":"European Journal of Paediatric Neurology"},{"issue":"2","key":"10.1016\/j.ymgme.2022.02.002_bb0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ymgme.2022.02.002_bb0070","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jcrs.2010.12.037","article-title":"Anatomy and physiology of the cornea","volume":"37","author":"DelMonte","year":"2011","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1511\/2003.11.28","article-title":"How the retina works","volume":"91","author":"Kolb","year":"2003","journal-title":"Am. Sci."},{"issue":"4","key":"10.1016\/j.ymgme.2022.02.002_bb0080","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/eye.2009.229","article-title":"Inherited metabolic disorders involving the eye: a clinico-biochemical perspective","volume":"24","author":"Rajappa","year":"2010","journal-title":"Eye"},{"issue":"2\u20133","key":"10.1016\/j.ymgme.2022.02.002_bb0085","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/A:1024493318913","article-title":"The eye as a window to inborn errors of metabolism","volume":"26","author":"Poll-The","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"issue":"36","key":"10.1016\/j.ymgme.2022.02.002_bb0090","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012124","article-title":"Ptosis in childhood: a clinical sign of several disorders: case series reports and literature review","volume":"97","author":"Pavone","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ymgme.2022.02.002_bb0095","article-title":"Eye involvement in inherited metabolic disorders","volume":"12","author":"Davison","year":"2020","journal-title":"Ther Adv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ymgme.2022.02.002_bb0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/WNO.0b013e3181f9a923","article-title":"Ptosis in pompe disease: common genetic background in infantile and adult series","volume":"30","author":"Ravaglia","year":"2010","journal-title":"J. Neuroophthalmol."},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ymgme.2019.02.002","article-title":"Ophthalmological findings in gaucher disease","volume":"127","author":"Eghbali","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2022.02.002_bb0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bjo.2006.100602","article-title":"Ocular manifestations of Fabry\u2019s disease: data from the fabry outcome survey","volume":"91","author":"Sodi","year":"2007","journal-title":"Br. J. Ophthalmol."},{"issue":"Suppl 2","key":"10.1016\/j.ymgme.2022.02.002_bb0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13052-018-0559-9","article-title":"Ocular features in mucopolysaccharidosis: diagnosis and treatment","volume":"44","author":"Del Longo","year":"2018","journal-title":"Ital. J. Pediatr."},{"issue":"5","key":"10.1016\/j.ymgme.2022.02.002_bb0120","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/014107688808100517","article-title":"The eye and inherited metabolic disease: a review","volume":"81","author":"Michalski","year":"1988","journal-title":"J. R. Soc. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2022.02.002_bb0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/0972-2327.99716","article-title":"Ocular signs in Wilson disease","volume":"15","author":"Amalnath","year":"2012","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"3","key":"10.1016\/j.ymgme.2022.02.002_bb0130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s13760-015-0566-1","article-title":"The sunflower cataract in Wilson\u2019s disease: pathognomonic sign or rare finding?","volume":"116","author":"Langwinska-Wosko","year":"2016","journal-title":"Acta Neurol. Belg."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2022.02.002_bb0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/mgme.2000.3062","article-title":"Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops","volume":"71","author":"Gahl","year":"2000","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2022.02.002_bb0140","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0039-6257(91)90185-I","article-title":"The peroxisome and the eye","volume":"35","author":"Folz","year":"1991","journal-title":"Surv. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0145","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.survophthal.2006.10.006","article-title":"Ophthalmic manifestations and histopathology of infantile nephropathic cystinosis: report of a case and review of the literature","volume":"52","author":"Tsilou","year":"2007","journal-title":"Surv. Ophthalmol."},{"issue":"9","key":"10.1016\/j.ymgme.2022.02.002_bb0150","first-page":"1297","article-title":"SRD5A3 defective congenital disorder of glycosylation: clinical utility gene card","volume":"28","author":"Jaeken","year":"2020","journal-title":"EuropeanJournal ofHuman Genetics : EJHG"},{"issue":"3","key":"10.1016\/j.ymgme.2022.02.002_bb0155","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/bjo.2008.145359","article-title":"Ophthalmological abnormalities in children with congenital disorders of glycosylation type I","volume":"93","author":"Morava","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ymgme.2022.02.002_bb0160","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10545-018-0156-5","article-title":"Recognizable phenotypes in CDG","volume":"41","author":"Ferreira","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.002_bb0165","series-title":"GeneReviews((R))","article-title":"Congenital disorders of N-linked glycosylation and multiple pathway overview","author":"Ferreira","year":"1993"},{"issue":"5","key":"10.1016\/j.ymgme.2022.02.002_bb0170","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/1346-8138.12170","article-title":"Albinism in Europe","volume":"40","author":"Martinez-Garcia","year":"2013","journal-title":"J. Dermatol."},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0175","first-page":"1","article-title":"Type I hyperprolinemia in a family suffering from aniridia and severe dystrophia of ocular tissues","volume":"173","author":"Fusco","year":"1976","journal-title":"International Journal of Ophthalmology"},{"key":"10.1016\/j.ymgme.2022.02.002_bb0180","doi-asserted-by":"crossref","DOI":"10.1177\/2633004020938061","article-title":"Congenital cataract: a guide to genetic and clinical management","volume":"1","author":"Bell","year":"2020","journal-title":"Therapeutic Advances in Rare Disease"},{"key":"10.1016\/j.ymgme.2022.02.002_bb0185","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-1-16","article-title":"Lowe syndrome","volume":"1","author":"Loi","year":"2006","journal-title":"Orphanet journal of rare diseases"},{"issue":"2","key":"10.1016\/j.ymgme.2022.02.002_bb0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10545-016-9990-5","article-title":"International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up","volume":"40","author":"Welling","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2022.02.002_bb0195","first-page":"77","article-title":"Pediatric cataract: challenges and future directions","volume":"9","author":"Medsinge","year":"2015","journal-title":"Clin. Ophthalmol."},{"issue":"5","key":"10.1016\/j.ymgme.2022.02.002_bb0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0039-6257(88)90095-1","article-title":"Galactose and cataract","volume":"32","author":"Stambolian","year":"1988","journal-title":"Surv. Ophthalmol."},{"issue":"12","key":"10.1016\/j.ymgme.2022.02.002_bb0205","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/archneur.59.12.1975-a","article-title":"Cerebrotendinous xanthomatosis: juvenile cataract and chronic diarrhea before the onset of neurologic disease","volume":"59","author":"Cruysberg","year":"2002","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0210","first-page":"1","article-title":"The natural history of homocystinuria due to cystathionine beta-synthase deficiency","volume":"37","author":"Mudd","year":"1985","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2009.09.009","article-title":"A revisit to the natural history of homocystinuria due to cystathionine beta-synthase deficiency","volume":"99","author":"Skovby","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0220","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13816810.2020.1821384","article-title":"Ocular manifestations in classic homocystinuria","volume":"42","author":"Gus","year":"2021","journal-title":"Ophthalmic Genet."},{"issue":"7064","key":"10.1016\/j.ymgme.2022.02.002_bb0225","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bmj.313.7064.1037","article-title":"Delay in diagnosis of homocystinuria: retrospective study of consecutive patients","volume":"313","author":"Cruysberg","year":"1996","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ymgme.2022.02.002_bb0230","first-page":"206","article-title":"Homocystinuria versus Marfan\u2019s syndrome: the therapeutic relevance of the differential diagnosis","volume":"27","author":"Boers","year":"1984","journal-title":"Neth. J. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10545-017-0089-4","article-title":"Isolated sulfite oxidase deficiency","volume":"41","author":"Claerhout","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2022.02.002_bb0240","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0161-6420(81)35031-3","article-title":"The natural history of gyrate atrophy of the choroid and retina","volume":"88","author":"Takki","year":"1981","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ymgme.2022.02.002_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2021.07.010","article-title":"A review of treatment modalities in gyrate atrophy of the choroid and retina (GACR)","author":"Balfoort","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2022.02.002_bb0250","series-title":"The Eye in Pediatric Systemic Disease","first-page":"359","article-title":"Ocular Manifestations of Inborn Errors of Metabolism","author":"Ganesh","year":"2017"},{"issue":"15","key":"10.1016\/j.ymgme.2022.02.002_bb0255","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM198104093041503","article-title":"Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina","volume":"304","author":"Sipila","year":"1981","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ymgme.2022.02.002_bb0260","series-title":"Encyclopedia of Molecular Mechanisms of Disease","first-page":"1033","article-title":"Iminoglycinuria","author":"Br\u00f6er","year":"2009"},{"issue":"3","key":"10.1016\/j.ymgme.2022.02.002_bb0265","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1001\/archopht.1982.01030030425007","article-title":"Atypical gyrate atrophy of the choroid and retina associated with iminoglycinuria","volume":"100","author":"Hayasaka","year":"1982","journal-title":"Arch. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ymgme.2022.02.002_bb0270","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1620\/tjem.135.331","article-title":"Atypical gyrate atrophy of the choroid and retina and iminoglycinuria","volume":"135","author":"Saito","year":"1981","journal-title":"Tohoku J. Exp. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2022.02.002_bb0275","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.oret.2019.01.023","article-title":"Retinal morphology in sjogren-larsson syndrome on OCT: from metabolic crystalline maculopathy to early-onset macular degeneration","volume":"3","author":"Staps","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0280","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1086\/381055","article-title":"Mutation of CERKL, a novel human ceramide kinase gene, causes autosomal recessive retinitis pigmentosa (RP26)","volume":"74","author":"Tuson","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2022.02.002_bb0285","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.exer.2013.03.003","article-title":"Specific sphingolipid content decrease in Cerkl knockdown mouse retinas","volume":"110","author":"Garanto","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ymgme.2022.02.002_bb0290","doi-asserted-by":"crossref","first-page":"105405","DOI":"10.1016\/j.nbd.2021.105405","article-title":"CERKL, a retinal dystrophy gene, regulates mitochondrial function and dynamics in the mammalian retina","volume":"156","author":"Ferreira","year":"2021","journal-title":"Neurobiology of disease"},{"issue":"7","key":"10.1016\/j.ymgme.2022.02.002_bb0295","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ophtha.2003.10.034","article-title":"Ocular manifestations of niemann-pick disease type B","volume":"111","author":"McGovern","year":"2004","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.survophthal.2013.02.005","article-title":"Beyond the cherry-red spot: ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders","volume":"59","author":"Chen","year":"2014","journal-title":"Surv. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0305","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/nyas.12990","article-title":"Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease)","volume":"1371","author":"Ouseph","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11\u201312","key":"10.1016\/j.ymgme.2022.02.002_bb0310","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ejmg.2014.09.004","article-title":"Clinico-pathological manifestations of variant late infantile neuronal ceroid lipofuscinosis (vLINCL) caused by a novel mutation in MFSD8 gene","volume":"57","author":"Mandel","year":"2014","journal-title":"European Journal of Medical Genetics"},{"issue":"7","key":"10.1016\/j.ymgme.2022.02.002_bb0315","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1167\/iovs.16-20608","article-title":"Specific alleles of CLN7\/MFSD8, a protein that localizes to photoreceptor synaptic terminals, cause a spectrum of nonsyndromic retinal dystrophy","volume":"58","author":"Ferreira","year":"2017","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0320","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ophtha.2014.07.040","article-title":"Mutations in MFSD8, encoding a lysosomal membrane protein, are associated with nonsyndromic autosomal recessive macular dystrophy","volume":"122","author":"Roosing","year":"2015","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ymgme.2022.02.002_bb0325","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s12098-020-03196-0","article-title":"Aicardi-goutieres syndrome presenting with congenital glaucoma","volume":"87","author":"Gowda","year":"2020","journal-title":"Indian J. Pediatr."},{"issue":"12","key":"10.1016\/j.ymgme.2022.02.002_bb0330","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.bbamcr.2006.09.010","article-title":"Peroxisome biogenesis disorders","volume":"1763","author":"Steinberg","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2022.02.002_bb0335","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymgme.2005.07.034","article-title":"Optic atrophies in metabolic disorders","volume":"86","author":"Huizing","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2022.02.002_bb0340","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/1531-8249(200008)48:2<188::AID-ANA8>3.0.CO;2-P","article-title":"The epidemiology of pathogenic mitochondrial DNA mutations","volume":"48","author":"Chinnery","year":"2000","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2022.02.002_bb0345","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0035-3787(05)85075-1","article-title":"An OPA3 gene mutation is responsible for the disease associating optic atrophy and cataract with extrapyramidal signs","volume":"161","author":"Verny","year":"2005","journal-title":"Rev. Neurol."},{"issue":"4","key":"10.1016\/j.ymgme.2022.02.002_bb0350","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.survophthal.2009.10.002","article-title":"The neuro-ophthalmology of mitochondrial disease","volume":"55","author":"Fraser","year":"2010","journal-title":"Surv. Ophthalmol."},{"issue":"12","key":"10.1016\/j.ymgme.2022.02.002_bb0355","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/mds.27484","article-title":"Eye movement disorders and neurological symptoms in late-onset inborn errors of metabolism","volume":"33","author":"Koens","year":"2018","journal-title":"Movement Disorders"},{"issue":"Pt 3a","key":"10.1016\/j.ymgme.2022.02.002_bb0360","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/eye.1998.100","article-title":"Ophthalmic abnormalities in homocystinuria: the value of screening","volume":"12","author":"Taylor","year":"1998","journal-title":"Eye"},{"key":"10.1016\/j.ymgme.2022.02.002_bb0365","series-title":"Pediatric Ophthalmology and Strabismus (Fourth Edition)","first-page":"449","article-title":"Chapter 44 - Inherited retinal disorders","author":"Michaelides","year":"2013"},{"issue":"6","key":"10.1016\/j.ymgme.2022.02.002_bb0370","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/APO.0000000000000230","article-title":"Pathologic Myopia","volume":"5","author":"Ohno-Matsui","year":"2016","journal-title":"Asia Pac. J. Ophthalmol. (Phila)"},{"issue":"3","key":"10.1016\/j.ymgme.2022.02.002_bb0375","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejpn.2014.02.002","article-title":"Homozygous p.R284* mutation in HEXB gene causing Sandhoff disease with nystagmus","volume":"18","author":"Ferreira","year":"2014","journal-title":"Eur. J. Paediatr. Neurology"},{"issue":"3","key":"10.1016\/j.ymgme.2022.02.002_bb0380","first-page":"200","article-title":"Ocular changes in mucopolysaccharidosis IV a (Morquio a syndrome) and long-term results of perforating keratoplasty","volume":"213","author":"Kasmann-Kellner","year":"1999","journal-title":"Int. J. Ophthalmology"},{"issue":"3\u20134","key":"10.1016\/j.ymgme.2022.02.002_bb0385","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/02643294.2017.1417249","article-title":"Cognitive impairments in inherited metabolic diseases: promises and challenges","volume":"35","author":"Romani","year":"2018","journal-title":"Cogn. Neuropsychol."},{"issue":"5","key":"10.1016\/j.ymgme.2022.02.002_bb0390","first-page":"180","article-title":"Progressive external ophthalmoplegia and the kearns-Sayre syndrome: a clinical and molecular study of 6 cases","volume":"105","author":"Barrientos","year":"1995","journal-title":"Med. Clin. (Barc.)"},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0395","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pediatrneurol.2006.08.007","article-title":"Early-onset ophthalmoplegia in Leigh-like syndrome due to NDUFV1 mutations","volume":"36","author":"Laugel","year":"2007","journal-title":"Pediatr. Neurol."},{"issue":"10","key":"10.1016\/j.ymgme.2022.02.002_bb0400","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/archopht.1981.03930020676010","article-title":"Ocular motor signs in some metabolic diseases","volume":"99","author":"Cogan","year":"1981","journal-title":"Arch. Ophthalmol."},{"issue":"6","key":"10.1016\/j.ymgme.2022.02.002_bb0405","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00055735-199412000-00013","article-title":"Ocular manifestations of metabolic disorders","volume":"5","author":"Iwata","year":"1994","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0410","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13023-021-01727-2","article-title":"Treatable inherited metabolic disorders causing intellectual disability: 2021 review and digital app","volume":"16","author":"Hoytema van Konijnenburg","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.ymgme.2022.02.002_bb0415","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/gim.2017.226","article-title":"The cost and diagnostic yield of exome sequencing for children with suspected genetic disorders: a benchmarking study","volume":"20","author":"Dragojlovic","year":"2018","journal-title":"Genet. Medicine"},{"issue":"3","key":"10.1016\/j.ymgme.2022.02.002_bb0420","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41436-020-00996-9","article-title":"The role of clinical response to treatment in determining pathogenicity of genomic variants","volume":"23","author":"Shen","year":"2021","journal-title":"Genet. Medicine"},{"issue":"11","key":"10.1016\/j.ymgme.2022.02.002_bb0425","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1007\/s12035-020-02052-8","article-title":"The Elovl4 spinocerebellar Ataxia-34 mutation 736T>G (p.W246G) impairs retinal function in the absence of photoreceptor degeneration","volume":"57","author":"Ferreira","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"13","key":"10.1016\/j.ymgme.2022.02.002_bb0430","first-page":"3742","article-title":"Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT)","volume":"24","author":"Haer-Wigman","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0435","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ophtha.2014.07.040","article-title":"Mutations in MFSD8, encoding a lysosomal membrane protein, are associated with nonsyndromic autosomal recessive macular dystrophy","volume":"122","author":"Roosing","year":"2015","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ymgme.2022.02.002_bb0440","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/hmg\/11.5.559","article-title":"Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa","volume":"11","author":"Bowne","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.1016\/j.ymgme.2022.02.002_bb0445","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/ng.2370","article-title":"Exome sequencing identifies NMNAT1 mutations as a cause of leber congenital amaurosis","volume":"44","author":"Chiang","year":"2012","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.ymgme.2022.02.002_bb0450","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ophtha.2017.03.010","article-title":"Whole-exome sequencing identifies biallelic IDH3A variants as a cause of retinitis pigmentosa accompanied by pseudocoloboma","volume":"124","author":"Pierrache","year":"2017","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ymgme.2022.02.002_bb0455","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ng.223","article-title":"Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle","volume":"40","author":"Hartong","year":"2008","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2022.02.002_bb0460","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/13816810.2015.1136336","article-title":"Screening for SLC7A14 gene mutations in patients with autosomal recessive or sporadic retinitis pigmentosa","volume":"38","author":"Sugahara","year":"2017","journal-title":"Ophthalmic Genet."},{"issue":"7","key":"10.1016\/j.ymgme.2022.02.002_bb0465","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1167\/iovs.12-9548","article-title":"Early onset retinal dystrophy due to mutations in LRAT: molecular analysis and detailed phenotypic study","volume":"53","author":"Dev Borman","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.ymgme.2022.02.002_bb0470","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1212\/01.WNL.0000055865.30580.39","article-title":"A mitochondrial tRNA(His) gene mutation causing pigmentary retinopathy and neurosensorial deafness","volume":"60","author":"Crimi","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ymgme.2022.02.002_bb0475","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1086\/302344","article-title":"Retinitis pigmentosa and progressive sensorineural hearing loss caused by a C12258A mutation in the mitochondrial MTTS2 gene","volume":"64","author":"Mansergh","year":"1999","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.ymgme.2022.02.002_bb0480","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/gim.2017.227","article-title":"A homozygous founder missense variant in arylsulfatase G abolishes its enzymatic activity causing atypical usher syndrome in humans","volume":"20","author":"Khateb","year":"2018","journal-title":"Genet. Medicine"},{"issue":"5","key":"10.1016\/j.ymgme.2022.02.002_bb0485","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ajhg.2015.09.012","article-title":"Recessive mutations in RTN4IP1 cause isolated and syndromic optic neuropathies","volume":"97","author":"Angebault","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2022.02.002_bb0490","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ajhg.2009.03.003","article-title":"TMEM126A, encoding a mitochondrial protein, is mutated in autosomal-recessive nonsyndromic optic atrophy","volume":"84","author":"Hanein","year":"2009","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2022.02.002_bb0495","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0888-7543(05)80271-X","article-title":"Three novel mutations of the ornithine aminotransferase (OAT) gene in gyrate atrophy","volume":"14","author":"Park","year":"1992","journal-title":"Genomics"},{"issue":"11","key":"10.1016\/j.ymgme.2022.02.002_bb0500","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1167\/iovs.05-0526","article-title":"Mutations in GRM6 cause autosomal recessive congenital stationary night blindness with a distinctive scotopic 15-hz flicker electroretinogram","volume":"46","author":"Zeitz","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.ymgme.2022.02.002_bb0505","doi-asserted-by":"crossref","DOI":"10.3390\/genes10090654","article-title":"Molecular therapies for inherited retinal diseases-current standingOpportunities and Challenges","volume":"10","author":"Vazquez-Dominguez","year":"2019","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/j.ymgme.2022.02.002_bb0510","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.drudis.2019.01.019","article-title":"Luxturna: FDA documents reveal the value of a costly gene therapy","volume":"24","author":"Darrow","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"17","key":"10.1016\/j.ymgme.2022.02.002_bb0515","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1056\/NEJMoa1813279","article-title":"Patient-customized oligonucleotide therapy for a rare genetic disease","volume":"381","author":"Kim","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2022.02.002_bb0520","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-018-0295-0","article-title":"Effect of an intravitreal antisense oligonucleotide on vision in leber congenital amaurosis due to a photoreceptor cilium defect","volume":"25","author":"Cideciyan","year":"2019","journal-title":"Nat. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222001342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719222001342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T11:13:45Z","timestamp":1706354025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719222001342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":104,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1096719222001342"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.02.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and biochemical footprints of inherited metabolic disorders. VII. Ocular phenotypes","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2022.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}